Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Metals Creek Resources Announces Additional Assays from Ogden Gold Project

Netco Silver Updates on Prospecting and Sampling Program at Toruel Project

IBC Advanced Alloys Updates on Exploration Progress Report from Utah Properties

Northern Gold Mining Announces Additional Assays from Garrcon Deposit

Cap-Ex Drill Announces Assay Results from Block 103 Iron Property

Corvus Gold Announces 2011 Drill Results from LMS Property in Alaska

Thiess Wins $1BN Mining Contract at OZ Minerals’ Prominent Hill

Rio Tinto Expands Pilbara Iron Operations

Record Earnings for BHP Billiton

Chile to Tender New Lithium Contracts

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.